Professional Summary
Professional Overview
Jen Valavanis is a seasoned financial executive with over 10 years of experience in corporate accounting, SEC reporting, and financial advisory services. As the Vice President and Corporate Controller at Avalo Therapeutics, she oversees all aspects of the company's accounting operations, financial reporting, and internal controls.
Experience Summary
Current Role
As the VP, Corporate Controller at Avalo Therapeutics, Jen is responsible for providing strategic financial leadership and ensuring the accuracy and integrity of the company's financial reporting. Her key achievements include:
- Implementing robust financial processes and controls to enhance operational efficiency and meet regulatory requirements
- Streamlining the SEC reporting process, resulting in a 20% reduction in reporting turnaround time
- Spearheading the implementation of a new ERP system, leading to improved data management and more informed decision-making
Career Progression
Prior to her current role, Jen held various positions at Avalo Therapeutics, including Director of SEC Reporting and Senior Manager of SEC Reporting. She also gained valuable experience as a Senior in the Financial Accounting Advisory Services (FAAS) and Audit Services practices at EY.
Throughout her career, Jen has demonstrated a strong analytical mindset, strategic planning abilities, and a deep understanding of financial reporting standards. Her versatile skill set and proven track record of success have been instrumental in driving positive outcomes for her employers.
Academic Background
Jen holds a Bachelor of Science degree in Accounting from the University of Richmond, where she was also a student-athlete. Her academic achievements include graduating cum laude and serving as the president of the University's Accounting Club.
Areas of Expertise
- Corporate accounting and financial reporting
- SEC compliance and regulatory reporting
- ERP implementation and process optimization
- Financial analysis and strategic decision-making
- Leadership and team management
Professional Impact
Jen's contributions have had a tangible impact on the organizations she has served. At Avalo Therapeutics, her strategic financial oversight and process improvements have enhanced the company's financial reporting, strengthened its internal controls, and supported its growth and sustainability.
Conclusion
With her extensive experience, technical expertise, and proven leadership abilities, Jen Valavanis is a valuable asset to Avalo Therapeutics. As the VP, Corporate Controller, she continues to drive financial excellence and contribute to the company's overall success.
